«Ƶ is taking its world-leading continuous glucose monitoring (CGM) technology to the next level — athletes without徱ٱ.
Our biowearable technology is CE marked and is the world’s first glucose sport biosensor designed for athletes.1
Here's how it works: «Ƶ’s biosensor continuously measures glucose levels of athletes, ages 16 and up, with a small round biosensor worn on the back of the upper arm for up to 14 days. The user will automatically receive streaming glucose data, via Bluetooth® wireless technology, every minute and these data are designed to work with compatible mobile apps.*
This over-the-counter product is based on «Ƶ's world-leading2 CGM technology FreeStyle Libre, which was originally developed for people living with diabetes.
But our biosensor goes a step further, showing the potential breadth of sensor-based technology beyond diabetes management.
While the market for high-tech diabetes devices, including CGMs and insulin pumps, is approximately $7 billion — the fastest growing medtech market over $1 billion3 — expanding the population that can benefit from CGMs beyond those with diabetes stands to substantially broaden the market for this technology.
"This is just the beginning,” said Jared Watkin, senior vice president of «Ƶ’s diabetes care business. “Our breakthrough sensing technology has the potential to go beyond glucose and provide a lens into what's happening in the human body that could provide meaningful insights into other conditions, treatments and ultimately improve health."
Share